All major pharmacy chains are attempting to navigate a drastically changed landscape, facing competition online and elsewhere ...

Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state ...

Cigna has brought merger talks with Humana back from the dead, according to a new report in Bloomberg.

CVS Health replaced its top executive as it warned that its coming earnings will once again fall short of Wall Street ...

Granted, each of these companies has its own, sometimes-complicated, narrative playing out, and there are particularities of ...

Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in ...

CVS Health Corp. named David Joyner as its new chief executive officer, ending a tumultuous tenure for Karen Lynch at the ...

The Senate Homeland Security Permanent Subcommittee on Investigations (PSI) released a report on Thursday revealing that the nation’s three largest ...

CVS Health stock sold for $72.08 a share when Karen Lynch became president and CEO in 2021. It closed at $60.35 on Friday.